MRCM
M&R Capital Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.67M | Sell |
111,274
-880
| -0.8% | -$68.6K | 1.91% | 14 |
|
|
2024
Q2 | $8.75M | Buy |
112,154
+111,265
| +12,516% | +$8.68M | 2.09% | 12 |
|
|
2024
Q1 | $60.2K | Hold |
889
| – | – | 0.01% | 215 |
|
|
2023
Q4 | $59.9K | Buy |
889
+202
| +29% | +$13.6K | 0.02% | 235 |
|
|
2023
Q3 | $46.5K | Hold |
687
| – | – | 0.01% | 243 |
|
|
2023
Q2 | $49.2K | Hold |
687
| – | – | 0.01% | 244 |
|
|
2023
Q1 | $47.7K | Hold |
687
| – | – | 0.01% | 242 |
|
|
2022
Q4 | $46.6K | Hold |
687
| – | – | 0.01% | 230 |
|
|
2022
Q3 | $37K | Hold |
687
| – | – | 0.01% | 237 |
|
|
2022
Q2 | $45K | Hold |
687
| – | – | 0.01% | 233 |
|
|
2022
Q1 | $45K | Hold |
687
| – | – | 0.01% | 240 |
|
|
2021
Q4 | $40K | Hold |
687
| – | – | 0.01% | 250 |
|
|
2021
Q3 | $41K | Hold |
687
| – | – | 0.01% | 243 |
|
|
2021
Q2 | $41K | Hold |
687
| – | – | 0.01% | 251 |
|
|
2021
Q1 | $34K | Hold |
687
| – | – | 0.01% | 250 |
|
|
2020
Q4 | $34K | Sell |
687
-150
| -18% | -$7.42K | 0.01% | 264 |
|
|
2020
Q3 | $45K | Buy |
837
+150
| +22% | +$8.07K | 0.01% | 248 |
|
|
2020
Q2 | $36K | Hold |
687
| – | – | 0.01% | 265 |
|
|
2020
Q1 | $30K | Hold |
687
| – | – | 0.01% | 270 |
|
|
2019
Q4 | $34K | Hold |
687
| – | – | 0.01% | 294 |
|
|
2019
Q3 | $30K | Hold |
687
| – | – | 0.01% | 317 |
|
|
2019
Q2 | $28K | Hold |
687
| – | – | 0.01% | 331 |
|
|
2019
Q1 | $26K | Hold |
687
| – | – | 0.01% | 334 |
|
|
2018
Q4 | $26K | Hold |
687
| – | – | 0.01% | 326 |
|
|
2018
Q3 | $27K | Hold |
687
| – | – | 0.01% | 345 |
|
|
2018
Q2 | $24K | Hold |
687
| – | – | 0.01% | 353 |
|
|
2018
Q1 | $24K | Hold |
687
| – | – | 0.01% | 361 |
|
|
2017
Q4 | $23K | Buy |
+687
| New | +$23K | 0.01% | 368 |
|